Clinical Trial

RELIEVE Study: NT 201 Intravesical Administration Using Vibe System (ViXe Combination Product) for the Treatment of Idiopathic Overactive Bladder

Study acronym: RELIEVE
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This Phase 2b study is a prospective, multicenter, double blind, randomized, placebo and sham controlled trial to assess the safety, efficacy and dose response of NT 201 delivered by the Vibe System in participants with idiopathic overactive bladder (OAB).
Trial Details
NCT Number NCT07553065
Lead Sponsor Vensica Therapeutics Ltd.
Collaborators: TFS Trial Form Support
Conditions Overactive Bladder (OAB)
Enrollment 210 participants
Start Date 2026-07
Primary Completion 2027-09 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-27